trending Market Intelligence /marketintelligence/en/news-insights/trending/n0yuVKiroLcrJPYFiIWaRA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Assembly Biosciences raises $143.7M via common stock, warrants offering

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Assembly Biosciences raises $143.7M via common stock, warrants offering

Assembly Biosciences Inc. raised about $143.7 million in gross proceeds from an offering of common stock and warrants.

The Carmel, Ind.-based biotech sold 6,287,878 common shares at $16.50 apiece in the offering, including full exercise by underwriters of their option to purchase an additional 1,136,363 shares.

Moreover, Assembly Biosciences also sold prefunded warrants to buy up to 2,424,242 common shares to a certain existing investor at about $16.50 per warrant.

The company plans to use the net proceeds from the offering to fund clinical trials, nonclinical studies, research and development, and for general corporate purposes.

Jefferies LLC, SVB Leerink LLC and William Blair & Co. LLC were the joint book-running managers, while Mizuho Securities USA LLC and Robert W. Baird & Co. Inc. were the co-managers for the offering.